Acro Biomedical (ACBM) Return on Assets (2016 - 2025)

Acro Biomedical's Return on Assets history runs 10 years deep, the most recent figure standing at 0.11% for Q4 2025.

• In Q4 2025, Return on Assets fell 10.0% year-over-year to 0.11%; the TTM figure through Dec 2025 stood at 0.11% (down 10.0% YoY), while the FY2025 annual figure was 0.04%, down 3.0% from the prior year.
• Return on Assets was 0.11% for Q4 2025 at Acro Biomedical, down from 0.05% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2021 to a low of 2.27% in Q4 2023.
• Historically, Return on Assets has averaged 0.28% across 5 years, with a median of 0.13% in 2021.
• The sharpest annual moves came in 2023 and 2024: Return on Assets sank 203 bps in 2023, then soared 226 bps in 2024.
• A 5-year view of Return on Assets shows it stood at 0.11% in 2021, then plunged by 116 bps to 0.24% in 2022, then sank by 853 bps to 2.27% in 2023, then soared by 99 bps to 0.01% in 2024, then plunged by 817 bps to 0.11% in 2025.
• The last three Return on Assets figures came in at 0.11% (Q4 2025), 0.05% (Q3 2025), and 0.01% (Q2 2025), per Business Quant data.